BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 3249392)

  • 1. [Determination of serum L-carnitine by an implication of Cobas Bio centrifugal analyzer and its clinical implication in health and disease].
    Matsuyama H; Morikawa K; Hasegawa T; Kuroda M
    Rinsho Byori; 1988 Nov; 36(11):1296-302. PubMed ID: 3249392
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance of serum carnitine in patients with liver diseases].
    Lin XH; Jiao LL; Xu GB; Tian GS
    Zhonghua Gan Zang Bing Za Zhi; 2006 May; 14(5):367-9. PubMed ID: 16732913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term effects of nocturnal haemodialysis on carnitine metabolism.
    Hothi DK; Geary DF; Fisher L; Chan CT
    Nephrol Dial Transplant; 2006 Sep; 21(9):2637-41. PubMed ID: 16822785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of chronic renal hemodialysis on serum total, free and acyl carnitine concentrations in adult chronic pyelonephritis patients.
    Alhomida AS
    Arch Med Res; 1997; 28(1):101-7. PubMed ID: 9078596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis.
    Evans AM; Faull R; Fornasini G; Lemanowicz EF; Longo A; Pace S; Nation RL
    Clin Pharmacol Ther; 2000 Sep; 68(3):238-49. PubMed ID: 11014405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients.
    Reuter SE; Faull RJ; Ranieri E; Evans AM
    Nephrol Dial Transplant; 2009 Mar; 24(3):990-6. PubMed ID: 18987259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carnitine metabolism in patients with chronic renal failure: effect of L-carnitine supplementation.
    Wanner C; Förstner-Wanner S; Rössle C; Fürst P; Schollmeyer P; Hörl WH
    Kidney Int Suppl; 1987 Oct; 22():S132-5. PubMed ID: 3480977
    [No Abstract]   [Full Text] [Related]  

  • 8. L-carnitine can be measured accurately--and cost-effectively.
    Rosenthal AF
    Nephrol News Issues; 2003 Jun; 17(7):10-1; author reply 11. PubMed ID: 12847956
    [No Abstract]   [Full Text] [Related]  

  • 9. [Determination of fructosamine on the Cobas-Bio centrifuge system. Importance of white reagent].
    Chalas J; Leluc R
    Ann Biol Clin (Paris); 1987; 45(3):300-3. PubMed ID: 3662138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Electromyographic changes induced by oral carnitine treatment in dialysis patients.
    Albertazzi A; Spisni C; Del Rosso G; Palmieri PF; Rossini PM
    Proc Clin Dial Transplant Forum; 1980; 10():1-6. PubMed ID: 7346837
    [No Abstract]   [Full Text] [Related]  

  • 11. Relationship between serum carnitine, acylcarnitines, and renal function in patients with chronic renal disease.
    Fouque D; Holt S; Guebre-Egziabher F; Nakamura K; Vianey-Saban C; Hadj-Aïssa A; Hoppel CL; Kopple JD
    J Ren Nutr; 2006 Apr; 16(2):125-31. PubMed ID: 16567268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure.
    Günal AI; Celiker H; Dönder E; Günal SY
    J Nephrol; 1999; 12(1):38-40. PubMed ID: 10203002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effect of intravenous l-carnitine on quality of life in chronic hemodialysis patients.
    Semeniuk J; Shalansky KF; Taylor N; Jastrzebski J; Cameron EC
    Clin Nephrol; 2000 Dec; 54(6):470-7. PubMed ID: 11140808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine in hemodialysis patients.
    Butler B
    Nephrol Nurse; 1983; 5(5):32-3. PubMed ID: 6557366
    [No Abstract]   [Full Text] [Related]  

  • 15. Carnitine levels in human serum in health and disease.
    Böhmer T; Rydning A; Solberg HE
    Clin Chim Acta; 1974 Nov; 57(1):55-61. PubMed ID: 4279150
    [No Abstract]   [Full Text] [Related]  

  • 16. Endocrine-metabolic effects of l-carnitine in patients on regular dialysis treatment.
    Albertazzi A; Capelli P; Di Paolo B; Pola P; Tondi P; Vaccario O
    Proc Eur Dial Transplant Assoc; 1983; 19():302-7. PubMed ID: 6878245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of L-carnitine on respiratory function tests in children undergoing chronic hemodialysis.
    Kavukçu S; Türkmen M; Salman S; Onvural B; Oktay G; Karaman O; Cevik NT
    Turk J Pediatr; 1998; 40(1):79-84. PubMed ID: 9673532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathophysiology of platelet anomalies and its analysis. (3). Platelet aggregation, with special reference to clinical evaluation of the platelet aggregation in patients with diabetes mellitus and those under chronic hemodialysis].
    Matsuo T
    Rinsho Byori; 1983 Nov; 31(11):1168-75. PubMed ID: 6672292
    [No Abstract]   [Full Text] [Related]  

  • 19. [Cirrhosis and renal failure: the influence of creatinine value on prognosis].
    Yaghi C; Sayegh R; Fayad N; Honein K; Bou Jaoude J; Khouri K
    J Med Liban; 2003; 51(1):15-23. PubMed ID: 15181956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis.
    Perna AF; Acanfora F; Satta E; Lombardi C; Capasso R; Ingrosso D; De Santo NG
    J Nephrol; 2007; 20(1):63-5. PubMed ID: 17347975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.